Importer of Controlled Substances Application: Wildlife Laboratories, LLC, 63141-63142 [2020-22069]
Download as PDF
<![CDATA[
63141
Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices
Issued: October 1, 2020.
Lisa Barton,
Secretary to the Commission.
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 3, 2020,
Halo Pharmaceutical Inc, 30 North
Jefferson Road, Whippany, New Jersey
07981, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–22027 Filed 10–5–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Controlled
substances
Drug Enforcement Administration
Drug
codes
Schedule
[Docket No. DEA–727]
Dihydromorphine ......
Hydromorphone ........
Bulk Manufacturer of Controlled
Substances Application: Halo
Pharmaceutical, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Halo Pharmaceutical, Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 7, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 7, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
9145
9150
I
II
The company plans to manufacture
Hydromorphone (9150) for distribution
to its customers. Dihydromorphine
(9145) is an intermediate in the
manufacture of Hydromorphone and is
not for commercial distribution. No
other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–22076 Filed 10–5–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–726]
ACTION:
Notice of application.
S&B Pharma, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 7, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 7, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 25, 2020, S&B
Pharma, LLC, 405 South Motor Avenue,
Azusa, California 91702, applied to be
registered as an bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma,
LLC
Drug Enforcement
Administration, Justice.
AGENCY:
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for use in product development and for
commercial sales to its customers. In
reference to drug code 7360 (Marihuana)
and 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture
both as synthetic substances. No other
activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
2010
7360
7370
1100
1105
1205
1724
2270
8333
9780
9801
Drug Enforcement Administration
[Docket No. DEA–725]
[FR Doc. 2020–22075 Filed 10–5–20; 8:45 am]
Importer of Controlled Substances
Application: Wildlife Laboratories, LLC
BILLING CODE 4410–09–P
Drug Enforcement
Administration, Justice.
ACTION:
17:52 Oct 05, 2020
Jkt 253001
I
I
I
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
AGENCY:
VerDate Sep<11>2014
Schedule
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\06OCN1.SGM
Notice of application.
06OCN1
63142
Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices
Wildlife Laboratories, LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 5, 2020. Such
persons may also file a written request
for a hearing on the application on or
before November 5, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on September 4, 2020,
Wildlife Laboratories, LLC, 1230 W Ash
Street, Unit D, Windsor, Colorado
80550–4677, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
Drug code
Etorphine HCL ................
Thiafentanil .....................
9059
9729
Schedule
II
II
The company plans to import the
listed controlled substances for
distribution to its customers. No other
activity for these drug codes is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–22069 Filed 10–5–20; 8:45 am]
ACTION:
Notice of application.
Eli Elsohly Laboratories has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 7, 2020. Such
persons may also file a written request
for a hearing on the application on or
before December 7, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
BILLING CODE P
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 17, 2020, Eli
Elsohly Laboratories, 5 Industrial Park
Drive, Oxford, Mississippi 38655,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–722]
Bulk Manufacturer of Controlled
Substances Application: Eli Elsohly
Laboratories
Drug Enforcement
Administration, Justice.
AGENCY:
Controlled substances
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Dihydromorphone ............................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (marihuana) and 7370 (THC), the
company plans to isolate these
controlled substances from procured
7350 (marihuana extract). In reference to
drug code 7360, no cultivation activities
are authorized for this registration. No
VerDate Sep<11>2014
17:52 Oct 05, 2020
Jkt 253001
other activities for these drug codes are
authorized for this registration.
[FR Doc. 2020–22068 Filed 10–5–20; 8:45 am]
PO 00000
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
William T. McDermott,
Assistant Administrator.
BILLING CODE P
7350
7360
7370
9145
1100
1105
9041
9050
9120
9143
9150
9180
9193
9300
9333
9652
Schedule
Meeting of the Compact Council for the
National Crime Prevention and Privacy
Compact
Federal Bureau of
Investigation, Department of Justice.
AGENCY:
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\06OCN1.SGM
06OCN1
]]>Agencies
[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Pages 63141-63142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22069]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-725]
Importer of Controlled Substances Application: Wildlife
Laboratories, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
[[Page 63142]]
SUMMARY: Wildlife Laboratories, LLC has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before November 5,
2020. Such persons may also file a written request for a hearing on the
application on or before November 5, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on September 4, 2020, Wildlife Laboratories, LLC, 1230 W
Ash Street, Unit D, Windsor, Colorado 80550-4677, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Etorphine HCL........................ 9059 II
Thiafentanil......................... 9729 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
distribution to its customers. No other activity for these drug codes
is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of FDA-approved or non-approved finished dosage forms for commercial
sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22069 Filed 10-5-20; 8:45 am]
BILLING CODE P
